Laura M Mackner1, Brandi N Whitaker2, Michele H Maddux3, Suzanne Thompson4, Cheyenne Hughes-Reid5, Megan Drovetta6, Bonney Reed7. 1. Division of Pediatric Psychology and Neuropsychology, Center for Biobehavioral Health, Nationwide Children's Hospital, The Ohio State University, Columbus, OH. 2. Department of Pediatrics Psychology Section, University of Arkansas for Medical Sciences, Little Rock, AR. 3. Division of Developmental and Behavioral Sciences/Division of Gastroenterology, Children's Mercy-Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO. 4. Department of Psychology, St. Louis Children's Hospital, St. Louis, MO. 5. Division of Pediatric Behavioral Health, Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE. 6. Department of Social Work, Children's Mercy-Kansas City, Kansas City, MO. 7. Emory + Children's Pediatric Institute, Atlanta, GA.
Abstract
OBJECTIVE: Rates of youth depression are increasing, and approximately 75% of adolescents with depression go unrecognized. Research in pediatric IBD documents increased depression risk, with rates up to 25%, as well as worse adherence and treatment outcomes associated with depressive symptoms. Evidence-based psychological interventions improve the physical and emotional health of these patients, highlighting the importance of detection and treatment. Psychosocial screening has been shown to increase the accurate identification of psychosocial problems and facilitate timely psychosocial intervention. The objective of this article is to establish clinical guidelines for depression screening in youth diagnosed with IBD and to provide resources for implementation. METHODS: The psychosocial screening task force group constituted of psychologists and social workers in the ImproveCareNow (ICN) learning health system reviewed research and clinical guidelines in other fields, and consulted with physicians, nurses, other psychosocial professionals, patients with IBD, and parents of children with IBD in ICN. RESULTS/ CONCLUSIONS: It is recommended that adolescents with IBD ages 12 and older be screened for depression annually. Additional practical recommendations for implementation, triage, and treatment within the pediatric gastroenterology clinic are also provided.
OBJECTIVE: Rates of youth depression are increasing, and approximately 75% of adolescents with depression go unrecognized. Research in pediatric IBD documents increased depression risk, with rates up to 25%, as well as worse adherence and treatment outcomes associated with depressive symptoms. Evidence-based psychological interventions improve the physical and emotional health of these patients, highlighting the importance of detection and treatment. Psychosocial screening has been shown to increase the accurate identification of psychosocial problems and facilitate timely psychosocial intervention. The objective of this article is to establish clinical guidelines for depression screening in youth diagnosed with IBD and to provide resources for implementation. METHODS: The psychosocial screening task force group constituted of psychologists and social workers in the ImproveCareNow (ICN) learning health system reviewed research and clinical guidelines in other fields, and consulted with physicians, nurses, other psychosocial professionals, patients with IBD, and parents of children with IBD in ICN. RESULTS/ CONCLUSIONS: It is recommended that adolescents with IBD ages 12 and older be screened for depression annually. Additional practical recommendations for implementation, triage, and treatment within the pediatric gastroenterology clinic are also provided.
Authors: Eva Szigethy; Elyse Kenney; Johanna Carpenter; Diana M Hardy; Diane Fairclough; Athos Bousvaros; David Keljo; John Weisz; William R Beardslee; Robert Noll; David Ray DeMASO Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-10 Impact factor: 8.829
Authors: Eva Szigethy; Simona I Bujoreanu; Ada O Youk; John Weisz; David Benhayon; Diane Fairclough; Peter Ducharme; Joseph Gonzalez-Heydrich; David Keljo; Arvind Srinath; Athos Bousvaros; Margaret Kirshner; Melissa Newara; David Kupfer; David R DeMaso Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-05-10 Impact factor: 8.829
Authors: Esti Iturralde; Rebecca N Adams; Regan C Barley; Rachel Bensen; Megan Christofferson; Sarah J Hanes; David M Maahs; Carlos Milla; Diana Naranjo; Avni C Shah; Molly L Tanenbaum; Sruthi Veeravalli; K T Park; Korey K Hood Journal: J Adolesc Health Date: 2017-08-19 Impact factor: 5.012
Authors: Anne E Kazak; Annah N Abrams; Jaime Banks; Jennifer Christofferson; Stephen DiDonato; Martha A Grootenhuis; Marianne Kabour; Avi Madan-Swain; Sunita K Patel; Sima Zadeh; Mary Jo Kupst Journal: Pediatr Blood Cancer Date: 2015-12 Impact factor: 3.167
Authors: Kevin A Hommel; Rachel N Greenley; Michele Herzer Maddux; Wendy N Gray; Laura M Mackner Journal: J Pediatr Gastroenterol Nutr Date: 2013-08 Impact factor: 2.839
Authors: Alexandra L Quittner; Janice Abbott; Anna M Georgiopoulos; Lutz Goldbeck; Beth Smith; Sarah E Hempstead; Bruce Marshall; Kathryn A Sabadosa; Stuart Elborn Journal: Thorax Date: 2015-10-09 Impact factor: 9.139
Authors: Clayton S Edwards; Caroline M Roberts; Marissa N Baudino; Nathan L Basile; Kaitlyn L Gamwell; Noel J Jacobs; Jeanne Tung; John E Grunow; Larry L Mullins; John M Chaney Journal: J Clin Psychol Med Settings Date: 2022-06-06